Navigation Links
Cepheid Reports 2013 Second Quarter Results
Date:7/18/2013

year is expected to be approximately 67 million, except in the event we have non-GAAP net income, in which case the share count would be approximately 72 million shares.

The following table reconciles net loss per share to the non-GAAP net income per share range:Guidance Range for YearEnding December 31, 2013Low HighNet Loss Per Share$
(0.30)$
(0.27)Stock Compensation Expense0.420.42Amortization of Purchased Intangible Assets0.060.06Non-GAAP Measure of Net Income Per Share$
.18$
.21Accessing Cepheid's 2013 Second Quarter Results Conference CallThe Company will host a management presentation at 2 p.m. Pacific Time on Thursday, July 18, 2013, to discuss the results.  To access the live webcast, please visit Cepheid's website at http://ir.cepheid.com at least 15 minutes before the scheduled start time to download any necessary audio or plug-in software.  A replay of the webcast will be available shortly following the call and will remain available for at least 90 days.

About CepheidBased in Sunnyvale, Calif., Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests.  By automating highly complex and time-consuming manual procedures, the Company's solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases.  Through its strong molecular biology capabilities, the Company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. For more information, visit http://www.cepheid.com.

Use of Non-GAAP MeasuresThe Company has supplemented its report
'/>"/>

SOURCE Cepheid
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Cepheid Welcomes Senior Vice President of Human Resources
2. Cepheid Reports Fourth Quarter and Full Year 2011 Results
3. Cepheid to Webcast Upcoming Financial Presentations
4. Cepheid Receives Grant to Develop Sample Processing and Amplification Methods for Detection of Bloodstream Bacteria
5. Diagnostic Marketing Association Names Cepheid 2011 Marketer of the Year
6. Cepheid Announces European Release of Xpert CT/NG and Xpert CT, Delivering Rapid Detection and Differentiation of Chlamydia and Gonorrhoeae
7. Cepheid Receives FDA Clearance for GeneXpert Infinity-80 System for Initial Use with Xpert Flu Assay
8. Cepheid Reports 2012 Second Quarter Results
9. Cepheid Announces Board of Directors Changes
10. Testing Positive for Stability & Growth - Research Report on CombiMatrix Corporation, Cepheid, PerkinElmer, Inc., Life Technologies Corp. and Laboratory Corp. of America Holdings
11. Cepheid Reports 2013 First Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... 02, 2015 In the five years ... has experienced robust growth. The industry, which consists of ... energy resources and other goods, has grown on account ... As a result, IBISWorld forecasts that industry revenue will ... $946.8 million over the five-year period, including an anticipated ...
(Date:3/2/2015)... March 2, 2015 VLP Therapeutics, LLC. ... company focusing on the research and development of ... agents based upon a novel and proprietary vaccine ... Sciences Impact Grant Award from the Montgomery County ... by MCDED, is awarded to life sciences companies ...
(Date:3/2/2015)... , March 2, 2015 ... and healthy whole food nutrition products reveal technological ... lifestyle related disorders such as hyperglycemia, obesity, insulin ... concerns.  Nutraceutical and Biotech Companies in focus today ... Nature Foods Ltd. (NYSE: ANFI ), ...
(Date:3/2/2015)... SANTA BARBARA, Calif. , March 2, 2015 ... a biotechnology company developing therapies for autoimmune and ... Trademark Office (USPTO) has issued an important new ... immune system function through the targeting of CLIP. ... the targeted peptide technology underlying VG Life Sciences, ...
Breaking Biology Technology:Laboratory Testing Services in Canada Industry Market Research Report Now Available from IBISWorld 2Laboratory Testing Services in Canada Industry Market Research Report Now Available from IBISWorld 3VLP Therapeutics Wins the 2015 Life Sciences Impact Grant Award from the Montgomery County Department of Economic Development 2Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 2Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 3Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 4Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 5Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 6Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 7VG Life Sciences Granted Key Composition Of Matter Patent 2VG Life Sciences Granted Key Composition Of Matter Patent 3
... ... overview of genome browsers enable researchers to quickly and effectively use these invaluable resources. ... Seattle, WA (PRWEB) April 26, ... updated tutorial suite on the Overview of Genome Browsers. , , , Ensembl is ...
... and ,S-HERTOGENBOSCH, The Netherlands , April 28, 2010 , ... technology for the generation of immune therapeutics, today,announced that it reached ... ,s-Hertogenbosch. Under the terms of the,agreement Pepscan will receive an undisclosed ... , , ...
... April 27, 2010 Immunovo,BV, a new biotechnology company looking to ... develop novel,therapeutics, secures seed funding from Dutch venture capital firms. , ... ,S-Hertogenbosch, ... new,biotechnology company developing a novel technology platform for the creation,of a new ...
Cached Biology Technology:New and Updated Online Tutorials for Ensembl Legacy and Overview of Genome Browsers 2New and Updated Online Tutorials for Ensembl Legacy and Overview of Genome Browsers 3Pepscan Signs Partnering Agreement With Immunovo for its Therapeutic Vaccine Portfolio 2Pepscan Signs Partnering Agreement With Immunovo for its Therapeutic Vaccine Portfolio 3Immunovo BV- A New Biotechnology Company is Announced 2
(Date:2/12/2015)... 12, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... 62/113114 for DISTRIBUTED METHOD AND SYSTEM TO ... patent further establishes NXT-ID,s position in the emerging "Internet ... the ability for multiple devices to collaborate with one ...
(Date:2/5/2015)... PARK, North Carolina , 5. Februar ... 35. Jahr als spezialisiertes Logistikunternehmen und hat ... als einzige klinische Logistikfirma (Clinical Logistics Organization ... Kernbotschaft der neuen Kampagne lautet First ... Lieferungen. Foto: http://photos.prnewswire.com/prnh/20150205/173753 ...
(Date:2/5/2015)... 2015   Marvin Test Solutions , ... test solutions for military, aerospace, and manufacturing ... TS-323 GENASYS Test Platform to ... is a high-performance PXI-based system designed to ... require performance functional testing. GENASYS features a ...
Breaking Biology News(10 mins):NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4
... who self-paid for their antiretroviral medications experienced interruptions in ... logistical disruptions. These treatment interruptions led to the ... These findings by a team led by researchers at ... UCSF are reported in the April 22, 2007 issue ...
... College of Medicine have discovered a new way to use ... enter cancer cells. , The research appears in the Jan. ... , All living cells defend themselves by walling off the ... around the cell's inner machinery and its DNA blueprints. ...
... Autophagy is a cellular process that enables cells to ... is initiated in tumor cells by chemotherapy and radiation, ... tumor cell death or helps tumor cells survive the ... model of B cell lymphomas, researchers from the University ...
Cached Biology News:Resistance to anti-HIV drugs in Uganda developed due to drug supply problems 2Buckyballs used as 'passkey' into cancer cells 2